Aprea Therapeutics Inc.
APRE | NASDAQ
$0.74
-$0.02 (-2.62%)
At close: Sep 21, 2026, 4:00 PM ET
$0.76
+$0.02 (+2.42%)
Pre-market:
Sep 22, 2026, 7:30 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -12.31M | -11.95M | -12.6M | -13.04M | -13.85M | -14.08M | -12.96M | -13.51M | -12.93M | -12.72M | -14.29M | -13.29M | -14.11M | -109.11M | -112.66M | -117.98M | -123.4M | -35.4M | -37.13M | -44.76M | -47.63M | -53.75M |
Depreciation & Amortization | 22.03K | 21.71K | 21.72K | 21.71K | 21.71K | 21.59K | 22.32K | 21.88K | 17.88K | 12.8K | 7.05K | -319 | 59.62K | 123.09K | 186.45K | 254.82K | 262.9K | 259.44K | 271.68K | 262.58K | 249.82K | 237.84K |
Stock-Based Compensation | 427.04K | 460.58K | 478.14K | 495.15K | 530.48K | 522.24K | 489.44K | 446.27K | 373.21K | 514.05K | 444.46K | 418.95K | 381.16K | 14.91M | 16.98M | 19.02M | 21.01M | 8.08M | 7.81M | 7.15M | 5.12M | 4.51M |
Other Working Capital | -89.83K | -80.08K | -282.39K | -455.74K | 251.88K | 267.73K | -741.19K | -1.1M | -887.52K | -1.41M | 791.25K | 686.08K | -253.35K | 272.25K | -900.07K | -3.26M | -4.57M | -3.2M | -5.6M | -2.48M | -686.41K | -1.01M |
Other Non-Cash Items | 42.78K | 74.86K | 134.37K | 47.43K | 77.24K | 53.61K | -54.37K | 63.43K | 30.82K | -31.05K | 38.93K | -6.09K | -33.32K | 72.39M | 72.24M | 72.14M | 72.18M | 68.37K | -317.4K | 926.66K | 268.61K | 1.91M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -352.6K | -622.32K | -929.1K | -969.61K | 479.54K | 231.85K | -1.06M | -809.88K | -1.05M | -913.26K | 1.62M | 414.64K | -3.11M | -817.97K | -1.76M | -4.6M | -2.87M | -4.67M | -8.33M | -4.29M | -3.64M | -424.2K |
Operating Cash Flow | -12.17M | -12.02M | -12.89M | -13.44M | -12.74M | -13.25M | -13.56M | -13.79M | -13.56M | -13.13M | -12.18M | -12.46M | -16.81M | -22.49M | -25.01M | -31.17M | -32.81M | -31.66M | -37.69M | -40.71M | -45.63M | -47.52M |
Capital Expenditures | -15.4K | n/a | n/a | n/a | n/a | -7.5K | -15.48K | -22.63K | -108.57K | -101.07K | -93.09K | -85.94K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -16.29K | -16.13K | -14.11K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -348 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -15.75K | n/a | n/a | n/a | n/a | -7.5K | -15.48K | -22.63K | -108.57K | -101.07K | -93.09K | -85.94K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -16.29K | -16.14K | -14.11K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -3.3M | -878.65K | -407.37K | -42.08K | -25.8K | -31.95K | -1.32M | -1.31M | -1.31M | -1.29M | -648.93K | -648.93K | -648.93K | -648.93K | n/a | 1.66M | 1.75M | 1.75M | 1.75M | 86.97K | n/a | 121.43K |
Financial Cash Flow | 36.89M | 39.21M | 4.64M | 933.07K | 573.98K | 168.04K | 14.82M | 14.69M | 14.69M | 14.71M | 5.14M | 5.24M | 5.82M | 5.82M | 682.97K | 2.24M | 1.75M | 1.75M | 1.75M | 86.97K | 9.14K | 130.57K |
Net Cash Flow | 24.7M | 27.19M | -8.25M | -12.53M | -12.16M | -13.09M | 1.24M | 897.2K | 1.01M | 1.42M | -7.14M | -7.72M | -11.34M | -16.66M | -24.29M | -28.32M | -30.74M | -29.96M | -35.94M | -39.72M | -43.06M | -44.9M |
Free Cash Flow | -12.18M | -12.02M | -12.89M | -13.44M | -12.74M | -13.26M | -13.57M | -13.81M | -13.67M | -13.24M | -12.27M | -12.54M | -16.81M | -22.49M | -25.01M | -31.17M | -32.81M | -31.66M | -37.69M | -40.72M | -45.65M | -47.53M |
Adj. Free Cash Flow | -12.61M | -12.48M | -13.37M | -13.94M | -13.27M | -13.78M | -14.06M | -14.25M | -14.04M | -13.75M | -12.72M | -12.96M | -17.19M | -37.41M | -41.99M | -50.18M | -53.82M | -39.73M | -45.5M | -47.88M | -50.76M | -52.04M |
Maintenance CapEx | -5.75K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -16.29K | -16.45K | -18.47K |
Growth CapEx | -9.65K | n/a | n/a | n/a | n/a | -7.5K | -15.48K | -22.63K | -108.57K | -101.07K | -93.09K | -85.94K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 310.43 | 4.35K |
Owner Earnings | -12.17M | -12.02M | -12.89M | -13.44M | -12.74M | -13.25M | -13.56M | -13.79M | -13.56M | -13.13M | -12.18M | -12.46M | -16.81M | -22.49M | -25.01M | -31.17M | -32.81M | -31.66M | -37.69M | -40.72M | -45.65M | -47.54M |
Add to Watchlist
Select watchlists to add or remove APRE